| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.38 | 2e-33 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.39 | 4e-30 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.37 | 1e-27 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.37 | 7e-16 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.27 | 6e-15 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-11 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-11 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.34 | 1e-10 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-10 |